SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-18-008496
Filing Date
2018-02-14
Accepted
2018-02-14 11:52:39
Documents
1
Group Members
DILIP S. SHANGHVISUN PHARMACEUTICAL INDUSTRIES LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv485820_sc13g.htm SC 13G 70646
  Complete submission text file 0001144204-18-008496.txt   72239
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Subject) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90133 | Film No.: 18609410
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address POLARISAVENUE 87 2132 JH HOOFDDORP P7 00000
Business Address POLARISAVENUE 87 2132 JH HOOFDDORP P7 00000 (609) 819-8200
Sun Pharma (Netherlands) B.V. (Filed by) CIK: 0001717322 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 0331
Type: SC 13G